Rehabilitation of neuropathies

Critical Reviews in Physical and Rehabilitation Medicine

Volumn 19, Issue 1, 2007, Pages 19-53

  Grisold, Wolfgang ^a   Vass, Andrea ^b   Schmidhammer, Robert ^c   Zifko, Udo ^d  

^a KAISER FRANZ JOSEF HOSPITAL   (Austria)

^b LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^c Unfallkrankenhaus Lorenz Bohler   (Austria)

^d Rehabilitation Clinic Bad Pirawarth 2222   (Austria)

Author keywords

Diabetic neuropathy; Neuropathies; Neuroplasticity; Neuropraxia; Neurorehabilitation; Polyneuropathies; Rehabilitation; Reinnervation

Indexed keywords

AMITRIPTYLINE; CAPSAICIN; CARBAMAZEPINE; CYCLOSPORIN A; DULOXETIN; DULOXETINE; FLUDROCORTISONE; GABAPENTIN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; LIDOCAINE; METOCLOPRAMIDE; OPIATE; PHENYTOIN; PREGABALIN; SEROTONIN UPTAKE INHIBITOR; SILDENAFIL; STEROID; UNCLASSIFIED DRUG; VENLAFAXIN; VENLAFAXINE;

APRAXIA; AUTONOMIC NERVE; BODY POSTURE; BONE MALFORMATION; CHEMOTHERAPY INDUCED TOXIC NEUROPATHY; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CONSTIPATION; DIABETIC NEUROPATHY; DISEASE COURSE; ELECTROMYOGRAPHY; FATIGUE; GAIT; GUILLAIN BARRE SYNDROME; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; IMPOTENCE; INJURY SCALE; INTERPERSONAL COMMUNICATION; MONONEUROPATHY; MORBIDITY; MOTOR NERVE; MOTOR PERFORMANCE; NERVE CELL PLASTICITY; NERVE FUNCTION; NERVE LESION; NERVE REGENERATION; NERVE TRANSECTION; NEURAPRAXIA; NEUROPATHIC PAIN; NEUROPATHY; PERIPHERAL NERVE; PERIPHERAL NEUROPATHY; POLYNEUROPATHY; PRIORITY JOURNAL; PROGNOSIS; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; REINNERVATION; REVIEW; SEDATION; SENSORY NERVE; SIDE EFFECT; SOCIAL ENVIRONMENT; STOMACH PARESIS; SUBACUTE SENSORY NEURONOPATHY; SYMPTOM; ULCER;

EID: 34249826357     PISSN: 08962960     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevPhysRehabilMed.v19.i1.20     Document Type: Review

References (131)

1. Stillwell GK, Thorsteinson G. Rehabilitation procedures. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, editors. Peripheral neuropathy. Vol. 2. Philadelphia: W. B. Saunders; 1993. p. 1692-708.
2. Braddom RL. Physical medicine & rehabilitation. 3rd ed. Philadelphia: Elsevier-Saunders; 2006.
3. Evans RW, Baskin DS, Yatsu FM. Prognosis of neurological disorders. New York/Oxford: Oxford University Press; 2000.
4. Burke SL, Higgins JP, McClinton MA, Saunders RJ, Valdata L. Hand and upper extremity rehabilitation. A practical guide. St Louis (MO): Elsevier: Churchill Livingstone; 2006.
5. Stewart DJ. Peripheral nerve fascicles: anatomy and clinical relevance. Muscle Nerve. 2003;28:525-41.
6. Molenaar DS, Vermeulen M, de Visser M, de Haan R. Impact of neurologic signs and symptoms on functional status in peripheral neuropathies. Neurology. 1999;52:151-6.
7. Rosenberg NR, Slotema CW, Hoogendijk JE, Vermeulen M. Follow up of patients with signs and symptoms of polyneuropathy not confirmed by electrophysiological studies. J Neurol Neurosurg Psychiatry. 2005;76:879-81.
8. Kerbaul F, Brousse M, Collart F, Pellissier JF, Planche D, Fernandez C, Gouin F, Guidon C. Combination of histopathological and electromyographic patterns can help to evaluate functional outcome of critical ill patients with neuro-muscular weakness syndromes. Crit Care. 2004;8:R358-66.
9. Rosenfeld J, Jackson CE. Quantitative assessment and outcome measures in neuromuscular disease. In: Katirji B, Kaminski HJ, Preston DC, editors. Neuromuscular disorders in clinical practice. Boston: Butterworth-Heinemann; 2002. p. 309-43.
10. Wagner MB, Katirji B. Rehabilitation management and care of patients with neuromuscular disease. In: Katirji B, Kaminski HJ, Preston DC. Neuromuscular disorders in clinical practice. Boston: Butterworth Heinemann; 2002. p. 344-63.
11. Merkies ISJ, Schmitz PIM, Van der Meche FGA, Samijn JPA, Van Doorn PA. Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies. J Neurol Neurosurg Psychiatry. 2002;72:596-601.
12. Merkies ISJ, Schmitz PIM, Ban der Meche FGA, Van Doorn PA. Psychometric evaluation of a new sensory scale in immune-mediated polyneuropathies. Neurology. 2000;54:943-9.
13. Padua L, Schenone A, Aprile I, Benedetti L, Calandro P, Tonali P, Orazio EN; Italian NEUROPA Study Group. Quality of life and disability assessment in neuropathy: a multicentre study. J Peripher Nerv Syst. 2005;10:3-10.
14. Hughes RA, Wijdicks EFM, Benson E, Cornblath DR, Hahn AF, Mezthaler JM. Supportive care for patients with Guillain Barre syndrome. Arch Neurol. 2005;62:1194-8.
15. Dyck PJ, Hughes RAC, O'Brien P. Quantitating overall neuropathic symptoms, impairments, and outcomes. In: Dyck PJ, Thomas PK. Peripheral neuropathy. Philadelphia: Elsevier; 2005. p. 1031-52.
16. Cavaletti G, Jann S, Pace A, Plasmati R, Siciliano G, Briani C, Cocito D, Padua L, Ghiglione E, Manicone M, Giussani G. Italian NETox Group. Multi-center assessment of the total neuropathy score for chemotherapy-induced peripheral neurotoxicity. J Peripher Nerv Syst. 2006;11(2):135-41.
17. Cornblath DR, Chaudhry V, Griffin JW. Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin. Ann Neurol. 1991;30:104-6.
18. Gorson KC, Ropper AH, Clark BD. Treatment of chronic inflammatory demyelinating polyneuropathy with interferon-alpha 2a. Neurology. 1998;50:84-7.
19. Van der Meche FG, Schmitz PI. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barre syndrome. Dutch Guillain-Barre Study Group. N Engl J Med. 1992;326:1123-9.
20. Plasma Exchange/Sandoglobulin Guillain Barre syndrome trial group. Randomised trial of plasma, intravenous immunoglobulin, and combined treatments in Guillain Barre syndrome. Lancet. 1997;349(9047):225-30.
21. Dyck PJ, Low PA, Windebank AJ. Plasma exchange in polyneuropathy associated with monoclonal gammopathy. New Engl J Med. 1991;325:1482-6.
22. Dyck PJ, Kratz KM, Lehmann KA, Karnes JL, Melton LJ III, O'Brien PC, Litchy WJ, Windebank AJ, Smith BE, Low PA, et al. The Rochester Diabetic Neuropathy Study: design, criteria for types of neuropathy, selection bias and reproducibility of neuropathic tests. Neurology. 1991;41:799-807.
23. Dyck PJ, Daube J, O'Brien P, Pineda A, Low PA, Windebank AJ, Swanson C. Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy. New Engl J Med. 1986;314:461-5.
24. Gorson KC, Allam G, Ropper AH. Chronic inflammatory demyelinating polyneuropathy clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy. Neurology. 1997;48:321-8.
25. Barnett MH, Pollard JD, Davies L, McLeod JG. Cyclosporine A in resistant chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve. 1998;21:454-60.
26. Demeurisse G, Demol O, Robaye E. Motor evaluation in vascular hemiplegia. Eur Neurol. 1980;19:382-9.
27. Kersten P. Principles of physiotherapy assessment and outcome measures. In: Stokes M, editor. Physical management in neurological rehabilitation. 2nd ed. Edinburgh: Elsevier-Mosby; 2004. p. 29-46.
28. Zinovieff AN. Heavy resistance exercises: the "Oxford technique." Br J Phys Med. 1951;14(6):129-32.
29. Jackson J. Specific treatment techniques. In: Stokes M, editor. Physical management in neurological rehabilitation. Edinburgh: Elsevier-Mosby; 2006. p. 393-411.
30. Paulson LE, Kilmer DD. Orthotic management of peripheral neuropathy. Phys Med Rehabil Clin N Am. 2001;12(2):433-45.
31. Lindeman E, Drukker J. Specificity of strength training in neuromuscular disorders. J Rehabil Sci. 1994;7(Suppl):13-5.
32. Pitetti KH, Barret PJ, Abbas D. Endurance exercise training in Guillain Barre syndrome. Phys Med Rehabil. 1993;74(7):761-5.
33. Bensman A. Strenuous exercise may impair muscle function in Guillain-Barre patients. JAMA. 1970;214:468-9.
34. Omer GE Jr. Evaluation and reconstruction of the forearm and hand after acute traumatic peripheral nerve injuries. J Bone Joint Surg. 1968;50:1454-78.
35. Levine DW, Simmons BP, Koris MJ, Daltroz LH, Hohl GG, Fossel AH, Katy JN. A self administered questionnaire for the assessment of severity of symptoms and functional status in carpal tunnel syndrome. J Bone Joint Surg. 1993;75A:1585-92.
36. Tonali P, Padua L, Sanguinetti C. Padua R, Romanici E, Amadio P. Outcome research and patient-oriented measures in the multiperspective assessment of neurological and musculoskeletal disorders. Consensus Conference: Third Roman Neurophysiology Day, Outcome Research in Neurology and in Musculoskeletal Disorders - 24 October 1998. Ital J Neurol Sci. 1999;20:139-40.
37. Bell-Krotoski J. Sensibility testing. In: Burke SL, Higgins JP, McClinton MA. Hand and upper extremity rehabilitation. St. Louis (MO): Elsevier-Churchill Livingstone, 2006. p. 53-76.
38. Larson RN. Desensitization and re-education. In: Burke SL, Higgins JP, McClinton MA, Saunders RJ, Valdata L, editors. Hand and upper extremity rehabilitation. St. Louis (MO): Elsevier-Churchill Livingstone; 2006. p. 151-63.
39. Anthony M. Sensory re-education. Adv Phys. 1994;5:19.
40. Nakada M, Uchida H. Case study of a five stage sensory reeducation program. J Hand Ther. 1997;10:232-9.
41. Dellon AL. Evaluation of sensibility and reeducation of sensation in the Hand. 3rd ed. Baltimore: Williams & Wilkins; 1988.
42. Wei FC, Ma HS. Delayed sensory reeducation after toe-to-hand transfer. Microsurgery. 1995;16:583.
43. Shieh SJ, Chiu HY, Lee JW, Hsu HY. Evaluation of the effectiveness of sensory reeducation following digital replantation and revascularization. Microsurgery. 1995;16:578-82.
44. Ramachandran VS. Phantom limbs and neural plasticity. Arch Neurol. 2000;57:317-20.
45. Chelimsky TC, Mehari E. Neuropathic pain. In: Katirji B, Kaminski HJ, Preston DC, Ruff RL, Shapiro B, editors. Neuromuscular disorders. Boston/Oxford: Butterworth-Heinemann; 2002. p. 1353-68.
46. Galer BS. Neuropathic pain of peripheral origin: advances in pharmacological treatment. Neurology. 1996;45 Supp:S17-25.
47. Grond S, Radbruch L, Meuser T, Sabatowski R, Loick G, Lehmann KA. Assessment and treatment of neuropathic cancer pain following WHO guidelines. Pain. 1999;79:15-20.
48. Devigili G, Tola MR, Tugnoli V, DeGennaro R, Casetta I, Lauria G, Granieri E. Itching syndrome as manifestation of neuropathic pain. J Peripher Nerv Syst. 2006;11:179-208 (Abstract).
49. Wolfe GI, Trivedi JR. Painful neuropathy and its nonsurgical treatment. Muscle Nerve. 2004;30:3-19.
50. Dubinsky RM, Gabbani H, El-Chami Z, Boutwell C, Ali H. Practice parameter: treatment of postherpetic neuralgia. Neurology. 2004;83:959-965.
51. Chong PST, Cros D. Technology literature review: quantitative sensory testing. Muscle Nerve. 2005;29:734-47.
52. Spillane JD, Nathan PW, Kelly RE, Marsden CD. The syndrome of painful legs and moving toes. Brain. 1971;94:541-56.
53. Birch R, Bonney G, Wynn Parry C. Surgical disorders of the peripheral nerves. London: Churchill Livingstone; 1998.
54. Cocito D, Paolasso I, Pazzaglia C. Tavella A, Poglio F, Ciaramitaro P, Scarmozzino A, Cossa FM, Bergamasco B, Padua L. Pain affects the quality of life of neuropathic patients. Neurol Sci. 2006 Jul;27(3):155-6.
55. McQuay HJ, Tramèr M, Nye BA, Carroll D, Wiffen P, Moore RA. A systematic review of antidepressants in neuropathic pain. Pain. 1996;68:217-27.
56. Sindrup SH, Jensen TS. Pharmacologic treatment of pain in polyneuropathy. Neurology. 2000;55(7):915-20.
57. Sindrup SH, Bach FW, Masden C, Gram LF, Jensen TS. Venlafaxine versus imipramine in painful polyneuropathy. Neurology. 2003;60:1284-9.
58. Gimbel JS, Richards P, Portenoy RK. Controlled release oxycodone for pain in diabetic neuropathy. Neurology. 2003;60:927-34.
59. Rowbotham MC, Twilling L, Davies P, Reisner L, Taylor K, Mohr D. Oral opioid therapy for chronic peripheral and central neuropathic pain. New Engl J Med. 2003;348:1223-32.
60. Wasner G, Kleinert A, Binder A, Schattschneider J, Baron R. Postherpetic neuralgia: topical lidocaine is effective in nociceptor deprived skin. J Neurol. 2005;252:677-86.
61. Chaudhry M, Stevens JC, Kincaid J, So YT. Practice advisory: utility of surgical decompression for treatment of diabetic neuropathy. Neurology. 2006;66(12):1805-8.
62. Selander D, Dhuner KG, Lundborg G. Peripheral nerve injury due to injection needles used for regional anesthesia. An experimental study of the acute effects of needle point trauma. Acta Anaesthesiol Scand. 1977;21(3):182-8.
63. Llewelyn JG, Tomlinson DR, Thomas PK. Diabetic neuropathies. In: Dyck PJ, Thomas PK, editors. Peripheral neuropathy. Philadelphia: Elsevier: Saunders; 2005. p. 1951-92.
64. McCallum RW, Ricci DA, Rakatansky H, Behar J, Rhodes JB, Salen G, Deren J, Ippoliti A, Olsen HW, Falchuk K. A multicenter placebo-controlled trial of oral metoclopramide in diabetic gastroparesis. Diabetes Care. 1983;6:463-7.
65. Lahrmann H, Cortelli P, Hilz M, Mathias CJ, Struhal W, Tassinari M. EFNS guidelines on the diagnosis and management of orthostatic hypotension. Eur J Neurol. 2006 Sep;13(9):930-6.
66. Graham RC, Hughes RAC. A modified peripheral neuropathy scale: the Overall neuropathy limitations scale. J Neurol Neurosurgery Psychiatry. 2006;77:973-9.
67. Tinetti ME. Performance-oriented assessment of mobility problems in elderly patients. J Am Geriatr Soc. 1986;34(2):119-26.
68. Berg KO, Wood-Dauphinee SL, Williams J, Maki B. Measuring balance in the elderly: validation of an instrument. Canadian J Public Health. 1989;83:S7-S11.
69. Mathis S, Nayak US, Isaacs B. Balance and the elderly patients: the "get up and go" test. Arch Phys Med Rehabil. 1986;67:387-9.
70. Bohannon RW. Selected determinants of ambulatory capacity in patients with hemiplegia. Clin Rehabil. 1989;3:47-53.
71. Vaney C, Blaurock H, Gattlen B, Meisels C. Assessing mobility in multiple sclerosis using the Rivermead mobility index. Clin Rehabil. 1996;10:216-26.
72. Hobart JC, Riazi A, Lamping DL, Fitzpatrick R, Thompson AJ. Measuring the impact of MS on walking ability: the 12 item multiple sclerosis walking scale (MSWS-12). Neurology. 2003;60:31-6.
73. Mueller MJ, Minor SD, Sahrmann SA, Strube MJ. Difference in gait characteristics of patients with diabetes and peripheral neuropathy compared with age-matched controls. Phys Ther. 1994;74:299-308.
74. Richardson JK, Sandman D, Vela S. A focused exercise regimen improves clinical measures of balance in patients with peripheral neuropathy. Arch Phys Med Rehabil. 2001;82(2):205-9.
75. Nicklin J. Disorders of nerve II: polyneuropathies. In: Stokes M, editor. Physical management in neurological rehabilitation. Edinburgh: Elsevier-Mosby, 2004. p. 253-67.
76. Charanya G, Patil KM, Narayanamurthy VB, Parivalavan R, Visvanathan K. Effect of foot sole hardness, thickness and footwear on foot pressure distribution parameters in diabetic neuropathy. Proc Inst Mech Eng. 2004;218:431-43.
77. Kurtyke JF. Neurologic impairment in Multiple Sclerosis and the Disability Status Scale. Acta Neurol Scand. 1970;46:493-512.
78. Granger CV, Hamilton BB, Linacre JM, Heinemann AW, Wright BD. Performance profiles of the functional independence measure. Am J Phys Med Rehabil. 1993;72:84-9.
79. Merkies ISJ, Schmitz PIM. Getting closer to patients: the INCAT Overall Disability Sum Score relates better to patients"' own clinical judgement in immune-mediated polyneuropathies. J Neurol Neurosurg Psychiatry. 2006;77:970-2.
80. van der Schaaf M, Beelen A, de Vos R. Functional outcome in patients with critical illness polyneuropathy. Disabil Rehabil. 2004;26(20):1189-97.
81. Verstappen CC, Heimans JJ, Hoekman K,, Postma TJ. Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management. Drugs. 2003;63(15):1549-63.
82. Vinik EJ, Hayes RP, Oglesby A, Bastyr E, Barlow P, Ford-Molvik SL, Vinik AI. The development and validation of the Norfolk QOL-DN, a new measure of patients' perception of the effects of diabetes and diabetic neuropathy. Diabetes Technol Therapeut. 2005;7(3):497-508.
83. Ware J Jr, Snow KK, Kosinski M, Gandek B. SF-36 health survey. Manual and interpretation guide. Boston (MA): Health Institute; New England Medical Center; 1993.
84. Postma TJ, Aaronson NK, Heimans JJ. The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20. Eur J Cancer. 2005;41(8):1135-9.
85. Langdon D. Pain management in neurological rehabilitation. In: Stokes M, editor. Physical management in neurological rehabilitation. Edinburgh: Elsevier-Mosby; 2006. p. 451-9.
86. Rajala U, Uusimaki A, Keinanen-Kiukaanniemi S, Kivela SL. Prevalence of depression in a 55 year old Finnish population. Soc Psychiatry Psychiat Epidemiol. 1994;29:126-30.
87. Fernandez E, Turk DC. The scope and significance of anger in the experience of chronic pain. Pain. 1995;61:165-75.
88. Jensen MP, Turner JA, Romano JM, Strom SE. The chronic pain coping inventory. Pain. 1995;60:203-16.
89. Bolton CF. Neuromuscular manifestations of critical illness. Muscle Nerve. 2005;32(2):140-63.
90. O'Gorman B, Oliver D, Nottle C, Prisley S. Disorders of nerve I: motor neurone disease. In: Stokes M, editor. Physical management in neurological rehabilitation. Edinburgh: Elsevier-Mosby; 2006. p. 233-51.
91. Stulemeijer M, de Jong LWAM, Fiselier TJF, Hoogveld SWB, Bleijenberg G. Cognitive behaviour therapy for chronic fatigue syndrome: a randomised controlled trial. BMJ. 2005;330:14-8.
92. Prins JB, Bleijenberg G, Bazelmans E, Elving LD, de Boo TM, Severens JL, van der Wilt GJ, Spinhoven P, van der Meer JW. Cognitive behaviour therapy for chronic fatigue syndrome: a multicentre randomised controlled trial. Lancet. 2001;357:841-7.
93. Merkies ISJ, Schmitz PI, Samijn JP, van der Meche FG, van Doorn PA. Fatigue in immune mediated polyneuropathies. Neurology. 1999;53:1648-54.
94. van der Werf SP, Prins JB, Vercoulen JH, van der Meer JW, Bleijenberg G. Identifying physical activity patterns in chronic fatigue syndrome using actigraphic assessment. J Psychosom Res. 2000;49(5):373-9.
95. Burrows DS, Cuetter AC. Residual subclinical impairment in patients who totally recovered from Guillain Barre syndrome. Impact on military performance. Mil Med. 1990;155(9):438-40.
96. Andersen PM, Borasio GD, Dengler R, Hardiman O, Kollewe K, Leigh PN, Pradat PF, Silani V, Tomik B; EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis. EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives. Eur J Neurol. 2005;12:9212-38.
97. Chio A, Gauthier A, Calvo A, Ghiglione P, Mutani R. Caregiver burden and patients perception of being a burden in ALS. Neurology. 2005;64:1780-2.
98. Van den Berg JP, Kalmijn S, Lindeman E, Veldink JH, de Visser M, Van der Graaff MM, Wokke JH, Van den Berg LH. Multidisciplinary ALS care improves quality of life in patients with ALS. Neurology. 2005;65:1264-7.
99. Lennon SM, Koblar S, Hughes RAC, Coeller J, Riser AC. Reasons for persistent disability in Guillain Barre syndrome. Clin Rehabil. 1993;7(1):1-8.
100. Nicholas R, Playford ED, Thompson AJ. A retrospective analysis of outcome in severe Guillain-Barre syndrome following combined neurological and rehabilitation management. Disabil Rehabil. 2000;22(10):451-5.
101. Pfeiffer G, Wicklein EM, Ratusinski T. Disability and quality of life in Charcot Marie Tooth disease type I. J Neurol Neurosurg Psychiatry. 2001;70(4):548-50.
102. White CM, Pritchard J, Turner-Stoks L. Exercise for people with peripheral neuropathy. Cochrane Database Syst Rev. 2004 Oct 18;(4):CD003904.
103. Lindeman E, Leffers P, Spaans F, Drukker J, Reulen J, Kerckhoffs M, Koke A. Strength training in patients with myotonic dystrophy and hereditary sensory neuropathy. A randomized clinical trial. Arch Phys Med Rehabil. 1995;76:612-20.
104. Ruhland J, Shields R. The effects of home exercise program on impairment and health-related quality of life in persons with chronic peripheral neuropathies. Phys Ther. 1997;77(10):1026-39.
105. Khatri A, Pearlstein L. Pain in Guillain-Barre syndrome. Neurology. 1997;49:1474.
106. Ropper H, Wijdicks EFM, Truax BT. Guillain-Barré syndrome. Philadelphia: FA Davis Company; 1991.
107. Nagaratnam N, Jamieson G, Chiu K, Ramos C. Critical illness neuropathy. Neurorehabil Neural Repair. 2001;15:81-4.
108. Rao N, Char D, Gnatz S. Rehabilitation outcomes of 5 patients with severe West Nile virus infection: a case series. Arch Phys Med Rehabil. 2005;86(3):449-52.
109. Ross MA. Neuropathies associated with diabetes. Med Clin N Am. 1993;77:111-124.
110. Stewart DJ. Diabetic truncal neuropathy: topography of the sensory deficit. Ann Neurol. 1989;25(3):233-8.
111. Bruce DG, Davies WA, Davis TM. Longitudinal predictors of reduced mobility and physical disability in patients with type 2 diabetes: the Fremantle diabetes study. Diabetes Care. 2005;28(10):2441-7.
112. Maty SC, Fried LP, Volpato S, Williamson J, Brancati FL, Blaum CS. Patterns of disability related to diabetes mellitus in older women. Gerontol A Biol Sci Med Sci. 2004;59:148-53.
113. Seddon H. Three types of nerve injury. Brain 1943;66:237.
114. Sunderland S. A classification of peripheral nerve injuries producing loss of function. Brain 1951;74:491.
115. Schmidhammer R, Hausner Th, Redl H. Enhanced sensory re-learning after nerve repair using 3D audiovisual signals and kinaesthesia. Acta Neurochirurgica. In press 2007.
116. Merzenich MM, Kaas JH, Wall JT, Sur M, Nelson RJ, Felleman DJ. Progression of change following median nerve section in the cortical representation of the hand in areas 3b and 1 in adult owl and squirrel monkeys. Neuroscience. 1983 Nov;10(3):639-65.
117. Garraghty PE, Kaas JH. Large-scale functional reorganization in adult monkey cortex after peripheral nerve injury. Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):6976-80.
118. Churchill JD, Muja N, Myers WA, Besheer J, Garraghty PE. Somatotopic consolidation: a third phase of reorganization after peripheral nerve injury in adult squirrel monkeys. Exp Brain Res. 1997;118:189-96.
119. Schroeder CE, Seto S, Garraghty PE. Emergence of radial nerve dominance in median nerve cortex after median nerve transection in an adult squirrel monkey. J Neurophysiol. 1997 Jan;77 (1):522-6.
120. Garraghty PE, Kaas JH. Functional reorganization in adult monkey thalamus after peripheral nerve injury. Neuroreport. 1991;2:747-50.
121. Churchill JD, Arnold LL, Garraghty PE. Somatotopic reorganization in the brainstem and thalamus following peripheral nerve injury in adult primates. Brain Res. 2001;910:142-52.
122. Mogilner A, Grossman JA, Ribary U, Joliot M, Volkmann J, Rapaport D, Beasley RW, Llinas RR. Somatosensory cortical plasticity in adult humans revealed by magnetoencephalography. Proc Natl Acad Sci U S A. 1993;90:3593-7.
123. Diesch E, Preissl H, Haerle M, Schaller HE, Birbaumer N. Multiple frequency steady-state evoked magnetic field mapping of digit representation in primary somatosensory cortex. Somatosens Mot Res. 2001;18:10-8.
124. Tinazzi M, Zanette G, Volpato D, Testoni R, Bonato C, Manganotti P, Miniussi C, Fiaschi A. Neurophysiological evidence of neuroplasticity at multiple levels of the somatosensory system in patients with carpal tunnel syndrome. Brain. 1998;121:1785-94.
125. Campero M, Serra J, Marchettini P, Ochoa JL. Ectopic impulse generation and autoexcitation in single myelinated afferent fibers in patients with peripheral neuropathy and positive sensory symptoms. Muscle Nerve. 1998;21:1661-7.
126. Nordin M, Nystrom B, Wallin U, Hagbarth KE. Ectopic sensory discharges and paresthesiae in patients with disorders of peripheral nerves, dorsal roots and dorsal columns. Pain. 1984;20(3):231-45.
127. Campbell JN, Khan AA, Meyer RA, Raja SN. Responses to heat of C-fiber nociceptors in monkey are altered by injury in the receptive field but not by adjacent injury. Pain. 1988;32(3):327-32.
128. Moore CE, Schady W. Investigation of the functional correlates of reorganization within the human somatosensory cortex. Brain. 2000;123:1883-95.
129. Schady W, Braune S, Watson S, Torebjork HE, Schmidt R. Responsiveness of the somatosensory system after nerve injury and amputation in the human hand. Ann Neurol. 1994;36:68-75.
130. Lundborg G. Nerve injury and repair: regeneration, reconstruction, and cortical remodeling. 2nd ed. Philadelphia: Elsevier: Churchill Livingstone; 2004.
131. Reddy H, Bendahan D, Lee MA, Johansen-Berg H, Donaghy M, Hilton-Jones D, Matthews PM. An expanded cortical representation for hand movement after peripheral motor denervation. J Neurol Neurosurg Psychiatry. 2002;72:203-10.